Acute respiratory distress syndrome resident survival guide

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Overview

Below is a table showing The Berlin definition of Acute Respiratory Distress Syndrome:[1]

Acute Respiratory Distress Syndrome
Timing ❑ Within 1 week of a known clinical insult or new or worsening respiratory symptoms
Chest imaging
i.e., CXR or CT
❑ Bilateral opacities—not fully explained by effusions, lobar/lung collapse, or

nodules

Origin of edema ❑ Respiratory failure not fully explained by cardiac failure or fluid overload
❑ Need objective assessment (e.g., echocardiography) to exclude hydrostatic edema
if no risk factor present
Oxygenation
(Corrected for altitude)
Mild ❑ 200 mm Hg < PaO2/FiO2 ≤ 300 mmHg with PEEP or CPAP > 5 cm H2O
Moderate ❑ 100 mm Hg < PaO2/FIO2 ≤ 200 mm Hg with PEEP ≥ 5 cm H2O
Severe ❑ PaO2/FiO2 ≤ 100 mm Hg with PEEP ≥ 5 cm H2O

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. This is a life-threatening condition with majority of patients requiring mechanical ventilation.

Common Causes

Management

 
 
Characterize the symptoms:
Chest pain
Cough
Cyanosis
Diaphoresis
Dyspnea
Fever
Hypotension
Tachycardia
Tachypnea
 
 
 
 
 
 
 
 
 
 
Patient evaluation:

Obtain a detailed history:
♦ Age
♦ History of heart disease
♦ History of chest infection


Examine the patient:
♦ Head/Neck - Neck veins (flat, no ↑JVP)
♦ Chest - No S3/S4, no murmurs
♦ Limbs - Hyperdynamic pulses, no edema
 
 
 
 
 
 
 
 
 
 
 
Urgent Labs:
ABG
❑ Calculate A-a gradient
CBC
Electrolytes
BUN
Creatinine
CXR - normal-sized heart, peripheral distribution of infiltrates, air-bronchogram (80%)

Consider additional tests, if necessary:

❑ Bronchoalveolar lavage - gram stain, culture & cytologyBronchoscopy
❑ BNP - <100 pg/mLCT
Echocardiography EKG - sinus tachycardia, non-specific ST-T wave changes
Lung biopsy ❑ PAWP - <15 mmHg
 
 
 
 
 
 
 
 
 
 
 
 
Diagnostic Criteria - The Berlin Definition
 
 
 
 
 
 
 
 
 
 
 
 
Emergent therapy
❑ Pulse oximetry
❑ Administer 100% oxygen - non-rebreather face masks, nasal prongs
❑ Initiate management of the underlying precipitating factor
❑ Consider right heart catheterization if hypotension persists
 
 
 
 
 
 
 
 
 
 
 
 
❑ Check vital signs
❑ Assess hemodynamic status:
♦ RR<35 bpm
♦ PaC02 <35 mmHg
♦ Sp02 >88%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable
 
Unstable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Maintain Sp02 between 88-95% by adjusting Fi02
❑ Treat underlying disease
 
❑ Transfer ICU
❑ Intubate (indications)
❑ Mechanical ventilation protocol
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supportive treatment
❑ Analgesia - morphine
❑ Conservative fluid management
❑ Conscious sedation - lorazepam
❑ DVT prophylaxis
❑ Glucose control
❑ Nurse 30-45 degrees head-up position
❑ Nutritional support (enteral feeds)
❑ NPO (in severely ill)
❑ Prevent pressure ulcers
❑ Stress ulcer prophylaxis - PPI
 

Mechanical Ventilation Protocol

 
 
 
 
 
 
❑ Calculate the predicted body weight (PBW)
Males - 50 + 2.3 [height (inches) - 60]
Females - 45.5 + 2.3 [height (inches) - 60]
❑ Ventilator mode - volume assist-control
❑ Set tidal volume (VT) to 8 ml/kg PBW
❑ ↓VT to 6 ml/kg PBW over the next 4 hours
❑ Flow rate - 60-80 lpm
❑ Ventilation rate - start at 18, adjust based on CO2
and ventilatory needs (max = 35 bpm)
❑ I:E ratio = 1:10 to 1:30
❑ Adjust VT and RR to achieve pH and plateau pressure
goals below
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oxygenation

Goal - Pa02 = 55 - 60 mmHg or Sp02 = 88 - 95%

❑ Start at FiO2 of 1.0 (100% O2); PEEP of 5 cmH2O
❑ Check ABG/pulse oximeter
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sp02 < 88%
 
Sp02 > 95%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjust FiO2/PEEP based on ARDSnet PEEP/FiO2 ladder
Monitor ABG
Note - Maintain FiO2 < 0.6
 
↓FiO2 until Sp02 is > 95%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess perfusion ( BP, urine output)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adequate
 
Inadequate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strict input/output monitoring
 
Administer volume (fluid management)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check plateau pressure

Goal - Pplat ≤ 30 cmH20

❑ Hold 'inspiratory hold' button for 0.5 seconds
❑ Check after each setting change or at least q 4hourly
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
> 30 cmH20
↓VT by 1 ml/kg steps
Min = 4 ml/kg
 
< 25 cmH20 & VT < 6 ml/kg
↑VT by 1 ml/kg until Pplat > 25 or VT = 6 ml/kg
 
< 30 + breath stacking or dys-synchrony
May ↑ VT in 1 ml/kg to 7 or 8 ml/kg, if Pplat remains ≤ 30 cmH20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Achieve pH goal

Goal = 7.30 - 7.45


pH 7.15 - 7.30 - ↑RR until pH > 7.30 or PaC02 < 25; max set RR = 35


pH <7.15
❑↑RR to 35; if pH is still < 7.15, ↑VT by 1 ml/kg until pH > 7.15 - you may exceed Pplat target of 30
❑ Give NaHC03


pH > 7.45 - ↓RR
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weaning
 
 
 

ARDSNet PEEP/FiO2 Ladder

FiO2 0.3 0.4 0.4 0.5 0.5 0.6 0.7 0.7 0.7 0.8 0.9 0.9 0.9 1.0
PEEP 5 5 8 8 10 10 10 12 14 14 14 16 18 20

Weaning

 
 
 
 
 
 
 
 
 
 
 
Conduct DAILY CPAP trial:

Criteria:
♦ Fi02 ≤ 0.40 & PEEP ≤ 8
♦ PEEP and FiO2 ≤ values of previous day
♦ Patient has spontaneous breathing efforts
(may decrease vent set rate by 50% for 5 minutes to detect effort)
♦ Systolic BP ≥ 90 mm Hg without vasopressor support
♦ No neuromuscular blocking agents or blockade


Process:
♦ Set CPAP to ≤5 cmH20; FiO2 to ≤0.50
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RR ≤ 35 bpm for 5 mins
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pressure support (PS) trial
♦ Set PEEP ≤ 5; FiO2 ≤ 0.50
Note - Set pressure support
based on RR during the CPAP trial
 
Discontinue trial
Return to previous A/C settings
Reassess next day or as directed by physician
Find out reasons for trial failure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CPAP RR < 25
 
CPAP RR = 25 - 35
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Set PS at 5 cm H20; PEEP at 5
 
Set PS at 20 cm H20; PEEP at 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess for tolerance (for up to 2 hours):
❑ Sp02 ≥ 90 &/or PaO2 ≥ 60%
❑ Spontaneous VT ≥ 4 ml/kg PBW
❑ RR ≤ 35 bpm
❑ pH ≥ 7.30
❑ No respiratory distress (any 2 or more)
♦ HR > 120% of baseline
♦ Marked accessory muscle use
♦ Abdominal paradox
♦ Diaphoresis
♦ Marked dyspnea
 
♦ ↓ PS by 5 q 1-3 hours (for RR ≤ 35)
or every 5 mins (for RR < 25)
♦ ↑ PS by 5 if RR > 35
Note - If PS is ≥ 10 cmH20 in the evening or RR > 35 @ PS of 20, resume A/C and attempt weaning the next day
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ ↑ PS by 5 when RR > 35
❑ Attempt weaning as ordered by physician
Note - PS of 5 or 10 cmH20 may be maintained overnight
 
Trial of unassisted breathing
Extubated with face masks, nasal prongs oxygen, or room air
or
T-tube breathing
or
Trach mask breathing
or
CPAP ≤ 5 cmH20 with no PS or IMV assistance
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reassess for tolerance
(same as above)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tolerated
(for at least 30 mins)
 
Not tolerated
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Extubate
 
Resume pre-weaning A/C settings
 
 

Dos

  • Nurse patient in semi-recumbent position (30-45 degrees) to reduce the risk of hospital-acquired pneumonia, especially those on enteral feeds.
  • Conscious sedation and analgesia to reduce oxygen consumption.
  • FiO2 is usually kept below 0.5 to reduce oxygen toxicity.
  • Daily spontaneous breathing trials.

Don'ts

References

  1. Ranieri, VM.; Rubenfeld, GD.; Thompson, BT.; Ferguson, ND.; Caldwell, E.; Fan, E.; Camporota, L.; Slutsky, AS.; Ranieri, V. (2012). "Acute respiratory distress syndrome: the Berlin Definition". JAMA. 307 (23): 2526–33. doi:10.1001/jama.2012.5669. PMID 22797452. Unknown parameter |month= ignored (help)

Template:WH Template:WS